CRC Earnings

CRC reported its FY2025Q4 earnings on 2026-03-02, showcasing a revenue of against an estimate of 786.68M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.49 by 0%. The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following CRC's FY2025Q4 earnings announcement on 2026-03-02, the stock price moved by 0% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, CRC's stock price tends to shift by an average of 5.22% in the 10 days leading up to earnings and 4.04% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate CRC's annual revenue to reach 780.54M, while the EPS is projected at 0.59. These estimates reflect recent revisions, with revenue estimates revised downward by -0.12% and EPS estimates revised downward by -0.51% over the past three months, indicating analyst expectation in the company's performance.

The correlation between CRC's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were revised downward by -0.12%, while EPS estimates moved revised downward by -0.51%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CRC's stock price typically moves by 5.22% in the 10 days before its earnings and 4.04% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.59 and revenue of 780.54M.

The company's earnings call presents a positive outlook with raised production guidance, improved financial metrics, and increased shareholder returns. The Q&A highlights strategic partnerships and operational efficiencies that enhance growth prospects. Despite some vague responses, the overall sentiment is positive, supported by strong financial management and a clear decarbonization strategy. The market cap suggests moderate sensitivity, resulting in a predicted positive stock price movement of 2% to 8% over the next two weeks.